Skip to main content
. 2017 Jun 15;29(2):273–283. doi: 10.1007/s00192-017-3377-5

Fig. 3.

Fig. 3

Mean (95% CI) OAB-S Medication Tolerability scores at end of treatment in the full analysis set: a by sequence, difference in period; b within period, difference in treatment; c overall treatment difference (primary endpoint)